← EPO Patent Bulletin

OPHTHALMIC FORMULATION FOR TOPICAL USE CONTAINING HELENALIN, 11A,13-DIHYDRO HELENALIN AND FLAVONOIDS FROM ARNICA MONTANA EXTRACT AND SODIUM HYALURONATE, AND USE THEREOF BY HUMANS TO TREAT DRY EYE SYNDROME

Publication EP4631513A1 Kind: A1 Mar 18, 2026

Applicants

Centro de Retina Médica Y Quirúrgica, S.C.

Inventors

SANTOS GARCÍA, Arturo, ALTAMIRANO VALLEJO, Juan Carlos, MORFIN HERAS, Pedro

IPC Classifications

A61K 36/28 20060101AFI20240614BHEP A61K 31/728 20060101ALI20240614BHEP A61P 27/02 20060101ALI20240614BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR